standard chemoradiotherapy

RADIATION3 trials

Sponsors

Sun Yat-sen University, Fudan University, Albert Einstein College of Medicine

Conditions

Advanced Rectal CancerNasopharyngeal CarcinomaNon-small Cell Lung Cancer

Phase 2

Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer

CompletedNCT03481114

Albert Einstein College of MedicineNon-small Cell Lung Cancer

Start: 2017-08-28End: 2023-12-27Updated: 2026-04-22

Phase 3

Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Sun Yat-sen UniversityAdvanced Rectal Cancer

Start: 2014-01-31End: 2025-12-31Target: 556Updated: 2023-08-25

Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage

Fudan UniversityNasopharyngeal Carcinoma

Start: 2018-01-01End: 2020-12-31Target: 360Updated: 2019-07-08

Related Papers

Short‐Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients

MedComm2025-07-23

SONCAR study: A prospective randomized controlled study on optimized neoadjuvant chemotherapy-oxaliplatin plus CRT in patients with locally advanced rectal cancer.

Journal of Clinical Oncology2022-01-192 citations

Predictive value of circulating tumor DNA in locally advanced rectal cancer patients receiving neoadjuvant radiochemotherapy.

Journal of Clinical Oncology2017-05-204 citations

The safety of four cycles of CAPEOX combined with radiotherapy vs. capecitabine combine with radiotherapy for locally advanced rectal cancer: Mid-term analysis of NCT02031939.

Journal of Clinical Oncology2016-05-20